CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus

09-23-2019 Press Release

Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of Agreement to Hold Big Pharma Accountable and Lower Drug Prices  For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday ahead of a U.S. House Committee on Energy and Commerce Subcommittee on […]

CSRxP: House Rx Package Adds to Unprecedented Momentum to Hold Big Pharma Accountable

09-19-2019 Press Release

Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from Both Sides of the Aisle For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the release of details of a drug pricing plan circulated by U.S. House Speaker Nancy Pelosi […]

CSRxP: HHS OIG REPORT DRASTICALLY UNDERCUTS BIG PHARMA’S BLAME GAME AT CRITICAL MOMENT IN WASHINGTON

09-13-2019 Press Release

Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes, Saved Program $8 Billion on Drug Costs For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today following the release of a new report from the U.S. Department of Health & Human […]

NEW STUDY: BIG PHARMA PRICE-GOUGING MEDICATIONS FOR RARE DISEASES AT STAGGERING RATE

09-11-2019 Press Release

Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs, AHIP Finds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today following the release of a new report from America’s Health Insurance Plans (AHIP) that found Big Pharma manipulated The Orphan Drug […]

CSRxP Commends Administration for Commitment to DTC Advertising Rule

08-21-2019 Press Release

Applauds HHS For Appealing Ruling Against List Price Transparency Measure   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today after the U.S. Department of Health and Human services appealed a federal ruling blocking the implementation of a measure to require drug […]

Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game

08-16-2019 Press Release

Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums Down A new report from the Government Accountability Office (GAO) undermines a common refrain in Big Pharma’s blame game targeting pharmacy benefit managers (PBMs) and rebates. In an effort to distract from their own price-gouging and anti-competitive behavior, Big Pharma frequently […]

CSRxP: Senate Finance Takes Positive Steps to Hold Big Pharma Accountable, Lower Drug Prices

07-25-2019 Press Release

Commends Bipartisan Collaboration on Several Market-Based Solutions, Cautions Committee Leaders Against Revival of Misguided Rebate Rule     For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday commending members of the U.S. Senate Committee on Finance for advancing a drug pricing package […]

CSRxP Applauds Grassley, Wyden for Moving Ahead on Drug Pricing Package

07-23-2019 Press Release

Looks Forward to Working With Senate Finance Members to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday commending Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) for moving ahead with a U.S. Senate Committee […]

Big Pharma Earnings Watch: Novartis

07-18-2019 Press Release

Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American Patients Today Big Pharma giant Novartis announced better-than-expected earnings for the second quarter of 2019. The brand name drug maker reported $11.76 billion in sales in Q2 – up from $11.34 billion last year – beating analysts’ expectations. As a result, the company raised its […]

Big Pharma Earnings Watch: Johnson & Johnson

07-17-2019 Press Release

Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019 It’s that time again. Pharmaceutical companies are starting to report their earnings for Q2. Big Pharma giant Johnson & Johnson out of the gate Tuesday. The brand name drug maker announced better-than-expected second quarter earnings and raised its sales forecast for […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.